RAJKUMAR VENKATRAMANI to Radiopharmaceuticals
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Radiopharmaceuticals.
Connection Strength
0.157
-
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children. Pediatr Blood Cancer. 2021 07; 68(7):e29056.
Score: 0.126
-
Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer Med. 2021 02; 10(3):857-866.
Score: 0.031